Newhill, NC, United States of America

Erwin A Vogler


Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 475(Granted Patents)


Company Filing History:


Years Active: 1993-1999

Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Erwin A Vogler in Anticoagulation Technology

Introduction: Erwin A Vogler, an accomplished inventor based in Newhill, NC, has made significant strides in the field of anticoagulation technology. With 18 patents to his name, Vogler’s work demonstrates a deep commitment to innovation in medical science. His latest inventions are set to revolutionize the way we approach blood coagulation and its reversal.

Latest Patents: Among Erwin A Vogler's recent patents are two noteworthy inventions:

1. **Rapidly Reversed Thrombin Binding Oligonucleotide Anticoagulants** - This invention introduces a system for the reversible anticoagulation of blood. It utilizes a nucleic acid ligand that binds to thrombin and a reversing agent that has a greater affinity for the ligand than thrombin does. This mechanism effectively prevents thrombin from converting fibrinogen to fibrin, thus anticoagulating the blood. Upon the addition of the reversing agent, thrombin is released, allowing for the natural coagulation process to resume.

2. **Bi-Directional Oligonucleotides that Bind Thrombin** - This patent presents bi-directional nucleic acid ligand compounds, where at least two oligonucleotides of opposite sequence polarity are linked by a connecting compound. This innovative design could be utilized for binding various protein or small molecule targets, serving as diagnostic or therapeutic agents in medical applications.

Career Highlights: Erwin A Vogler works at Becton Dickinson and Company Limited, a prominent organization in the medical technology sector. His innovative efforts not only contribute to the company's portfolio but also enhance the overall landscape of anticoagulation strategies. With nearly two decades of experience and multiple patents, Vogler continues to be a leading voice in his field.

Collaborations: Throughout his career, Vogler has collaborated with talented professionals, including his notable coworkers, Jane C Graper and Thomas A Shepard. These collaborations reflect his commitment to teamwork and the sharing of ideas, which are essential components of successful innovation.

Conclusion: Erwin A Vogler exemplifies the spirit of innovation in the medical field, demonstrating how inventions can lead to significant advancements in healthcare. His work at Becton Dickinson and Company Limited, alongside talented colleagues, positions him as a prominent figure in the development of new anticoagulation techniques, potentially saving lives and improving patient outcomes. The future of his inventions promises to further enhance the medical industry's capabilities in managing blood coagulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…